CEO John Rim Signals Interest in Acquiring GLP-1 Production Facilities amid Rising Obesity Drug Demand John Rim, CEO of Samsung Biologics, revealed that he has an interest in acquiring peptide production facilities, which are experiencing surging demand amid the global obesity treatment craze
Seven of 8 patients died within 1 year
Discontinuation typically results in weight regain, with patients recovering approximately two-thirds of lost weight within 12 months after stopping treatment
Start slowly, monitor your bodys response, and work with your provider to ensure safety and effectiveness
The best outcomes come from medically supervised care that combines the right therapy with protein, resistance training, metabolic monitoring, and an individualized long-term plan